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In the three-dimensional model of adenylate kinase, the phosphate-binding site for AMP and ATP has been 
identified [Pai, E.F. et al. (1977) J. Mol. Biol. 114, 37451. In this region one can distinguish a sequence 
glycine XXXX glycinelysine. The same sequence is found in many other mononucleotide-binding proteins 
including elongation factors and oncogenic P2 I proteins. Dinucleotide-binding proteins display a pyrophos- 
phate-binding unit with a glycine pattern different from that of mononucleotide-binding proteins. It has 
been found that P2l ras protein possesses a strand motif typical for (pyro)phosphate binding of a mononu- 
cleotide. A single mutation at position 12 can confer oncogenic activity on the protein. Based on the assump- 
tion that amino acid residues which are critical for function are preferentially conserved, we predict from 
the sequence that glycine residue I5 rather than residue I2 is important for (pyro)phosphate binding. 
Mononucleotide-binding protein Dinucleotide-binding protein Adenylate kinase 
P21 ras protein Phosphate-binding region 
Elongation factor 
1. INTRODUCTION 
Guanine nucleotide-binding proteins are impor- 
tant in protein synthesis, hormone action and 
tubulin assemblage [l]. Their conformation 
depends on the state of the nucleotide bound and 
this fact may be instrumental for the association 
and the dissociation with their neighbors [2]. 
The transforming ras genes of Harvey and 
Kirsten murine sarcoma viruses encode for a 
guanine nucleotide-binding protein, named P21 
[3]. A single nucleotide substitution of guanine in- 
to thymine in the normal cellular proto-oncogene 
leads to activation of the P21 protein gene [4,5]. 
This substitution corresponds to a Gly-+Val 
replacement at position 12 of P21 protein, thereby 
possibly inducing T24 and EJ bladder carcinoma 
14751. 
Although the precise biochemical function of 
P21 protein is unknown, comparative properties of 
P21 ra.s molecules coded for by viral and cellular 
ras genes have established that all known members 
of the ras gene family bind guanine nucleotides 
[6,7]. Interestingly, it has been noticed that the 
amino acid sequence surrounding position 12 of 
P21 protein resembles a loop which is part of a 
nucleotide-binding site in an ATP-binding [8] and 
in a dinucleotide-binding [9] protein. As a result 
the prediction has been made that the Gly+Val 
replacement would alter the nucleotide-binding 
properties such as to lead to induction of transfor- 
mation [8,9]. However, the question can be raised 
as to how valid comparisons of P21 proteins with 
ATP- or dinucleotide-binding enzymes [8,9] are, 
especially since there is no evidence that ATP or 
dinucleotides bind to P21 protein. A comparison 
of P21 with guanine nucleotide-binding proteins in 
the region of the pyrophosphate moiety is 
therefore of interest. In addition, it is worth know- 
ing whether the properties of the phosphate- 
binding region of nucleotide-binding proteins obey 
certain rules which are dependent on the nature of 
the base and are different for mono- and 
dinucleotides. 
2. SEQUENCE CHARACTERISTICS OF 
MONONUCLEOTIDE-BINDING 
PROTEINS 
We decided to focus first on possible common 
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features in the amino acid sequence of 
mononucleotide-binding proteins. A search among 
this class of proteins gave a pattern as given in 
table 1. 
A clue that the recurrent sequence GXXXXGK 
in the different mononucleotide-binding proteins 
of table 1 is not purely coincidental but reflects a 
special strand motif directed towards 
(pyro)phosphate binding came from X-ray 
crystallographic studies on adenylate kinase. It has 
been found by Pai et al. [lo] that in the crystal 
structure of adenylate kinase the phosphate moiety 
of AMP is surrounded by a loop, connecting a ,8- 
sheet to an cu-helix. The amino acid sequence of 
this loop, residues 16-23, coincides with the se- 
quence “GGPGSGK” of table 1. The wide-spread 
occurrence of the sequence GXXXXGK among 
mononucleotide-binding proteins suggests that in 
general it represents a structurally and energetical- 
ly favorable strand design for binding the 
(pyro)phosphate group. 
Inspection of table 1 shows that the oncogenic 
substitution Gly 12+Val 12 in the PEJ/T24 on- 
cogene product P21 occurs at a position of an 
Table 1 
Mononucleotide-binding proteins 
Residue Sequence 
number 
Ref. 
(A) Adenine nucleotide-binding proteins 
Adenylate kinase (porcine, human, rabbit) 
GTP : AMP phosphotransferase 
(beef-heart mitochondria) 
ATPase (&subunit) (bovine) 
Nitrogenase Fe-proteins (7 different species; 
two given) 
(B) Guanine nucleotide-binding proteins 
(a) P21 proteins 
v-ras H 
v-ras K 
pEWnorma c-has/has 1 
pEJ/T24 oncogene cHa-ras-I 
YP2 (S. cerevisiae) 
c-rasSc-’ (S. cerevisiae) 
(b) Transducing G-proteins 
Transducin T, 32 
G-protein G, 37 
(c) Elongation and initiation factors 
EF-Tu (E. co/i) 
EF-Tu (S. cerevisiae mitochondria) 
EF-Tu (E. gracilis chloroplasts) 
EF-br (Artemia) 
EF-la (S. cerevisiae) 
EF-G (E. co/r) 
IF-2 (E. co10 
(d) Tubulin proteins 
a-Tubulin (porcine brain) 
,&Tubulin (porcine brain) 
9-23 KI I FVVCGPGSUGT 
6-20 LLRAI MGAPGSGKGT 
150-164 GKI GLFGGAGVGKTV 
RQI AFYGKGGI GKS T 
RQCAI YGKGGI GKS T 
4-18 YKLVVVGARGVGKSA 1251 
4-18 YKLVVVGASGVGKSA WI 
4-18 YKLVVVGAGGVGKSA I4951 
4-18 YKLVVVGAVGVGKSA 14951 
9-23 FKLLLI GNSGVGKSC 1271 
1 l-25 TKI VVVGGGGVGKS A VI 
VKLLLLG_AGESmST 
VKLLLLGAGESGKST 
12-26 VNVGTI Q_HVDHmTT [29-311 
49-63 VNI GTI GHVDHGKTT 1321 
13-27 I NI CT1 GHVDHGKTT I331 
7-21 I NI VVI CHVDS GKS T [341 
8-22 I NVVVI GHVDS GK_S T I359361 
lo-24 RN1 GI S&HI DAGKTT I371 
392-406 PVVTI MG_HVDHmTS I381 
136-150 S VF HS F GGGT GS GF T 
134-148 QLTHS LGGGTGS GMG 
[21-231 
1241 
118,191 
1201 
WI 
1141 
I141 
I391 
1401 
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amino acid that is quite variable in different P21 
proteins as opposed to the invariant glycine residue 
at position 15. 
Therefore, it is not a priori clear that substitu- 
tion of Gly 12+Val 12 should decrease nucleotide 
binding to P21 protein due to steric hindrance of 
the phosphate moiety of bound GDP by a valine 
residue (cf. [9]). From this viewpoint a substitution 
at Gly 15 is expected to have a greater influence on 
GDP binding. In fact, the replacement Gly 
12-+Val 12 in P21 protein did not reveal a major 
alteration in its ability to bind guanine nucleotides 
[l 11. It looks as if the transforming properties of 
PEJ/T24-P21 protein are related to an unknown 
change in the secondary structure of the 
(pyro)phosphate-binding region resulting in a 
lower GTPase activity and in a different gross con- 
formation of the protein [l 11. 
Earlier model calculations of the three- 
dimensional structure of the PEJ/T24 oncogene 
product indicate that the Gly 12 peptide has a con- 
formation and flexibility which are larger than 
those of the Val 12 peptide [12]. These differences 
may well influence the rate of transition between a 
GTP and GDP conformation of the protein. Con- 
formational differences between the GTP and 
GDP form of guanine nucleotide-binding proteins, 
for instance, elongation factor EF-Tu, have been 
observed by means of spectral and chemical means 
PI. 
P21 protein resembles the class of transducing 
G-proteins [13] and its exchange of GDP for GTP 
proceeds somewhat analogously to that of EF-Tu 
under influence of EF-Ts. A clear, structural 
homology of P21 protein with G-protein or 
transducin has been demonstrated in the region 
purported to be essential for nucleotide binding 
(see table 1 and [14]). 
Concerning the elongation factors, we prefer the 
alignment as given first by Ilalliday [ 151 for EF-Tu 
from E. coli rather than the EF-Tu sequence near 
Gly 222 and Gly 224, mentioned by Duisterwinkel 
et al. [16] as part of the (pyro)phosphate-binding 
loop. Although residues 222-229 of EF-Tu have 
the sequence 224GXXXXGR229, the likelihood that 
the N-terminal region of EF-Tu contains the 
phosphate-binding roup seems to us greater for 
the following reasons: A better homology with all 
the other mononucleotide-binding proteins and the 
consistency of the proposed location of the 
(pyro)phosphate group near the N-terminal end of 
the protein. Publication of X-ray structure details 
of the binding of GDP to EF-Tu from E. coli will 
be an independent judge of the uniqueness of this 
consensus equence for (pyro)phosphate binding. 
The larger sequence homology within the group 
of protein synthetic factors, compared to other 
mononucleotide-binding proteins (table l), is in 
line with the idea that these factors interact with a 
common region of the ribosome including proteins 
L7, L12, LlO and Lll, known to be involved in 
GTP hydrolysis [ 171. 
Similar sequences are also found in bovine 
ATPase @-subunit) [18,19], and a number of Fe- 
proteins reviewed in [20] containing bound 
MgATP and MgADP (table 1). In the N-terminal 
region of Fe-proteins, resemblance in sequence to 
the loop region of adenylate kinase was noted and 
therefore this region was held to form a part of an 
adenylate-binding domain [20]. 
3. SEQUENCES IN DINUCLEOTIDE- 
BINDING PROTEINS 
X-ray analysis of FAD- and NAD-binding en- 
zymes has revealed striking structural similarities 
in nucleotide-binding fold patterns. Especially 
characteristic is the binding of the dinucleotide at 
the C-terminal ends of the parallel P-strands of 
Rossmann folds [41-441. A detailed comparison 
of the three-dimensional structure of glutathione 
reductase and p-hydroxybenzoate hydroxylase in 
the FAD- and NAD-binding domains shows that, 
in all cases, the pyrophosphate group of the 
dinucleotide approaches a very short loop connect- 
ing the first &strand and the following a-helix of 
a ,&fl unit [45]. In this connecting region one can 
distinguish two especially conserved glycine 
residues, the first having torsion angles @,+) in an 
exceptional region, the second having (+,+) values 
at the border of the allowed region for glycine and 
being close to the pyrophosphate group. A third 
glycine or alanine is in the a-helix opposing the p- 
strand. The presence of the pyrophosphate group 
close to the second invariant glycine residue at the 
amino-terminal end of the a-helix is in agreement 
with the prediction of a neutralizing dipole field on 
a negative charge [46]. 
These three glycine residues are also 
recognizable in a number of other dinucleotide- 
3 
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binding proteins if one aligns their primary struc- 
ture against those of which the three-dimensional 
structure is known. Judged from the data of table 
2, which includes recent examples given by Rice et 
al. [47], the sequence XhXhGXG, two 
hydrophobic amino acids, followed by two glycine 
residues which are separated by one amino acid, 
represents the minimal phosphoryl-binding region 
of a large number of dinucleotide-binding 
proteins. 
A third glycine XhXhGXGXXG is often present 
but is sometimes replaced by alanine, 
XhXhGXGXXA (see table 2). In horse liver 
alcohol dehydrogenase [48], glutathione reductase 
[49], and p-hydroxybenzoate hydroxylase [45], the 
two invariant hydrophobic amino acids and the 
first invariant glycine residue are near the end of a 
P-sheet while the second and third glycine residues 
are in an a-helix and possess properties, described 
above for glutathione reductase and p- 
hydroxybenzoate hydrolyase (see also table 3). 
It should be mentioned that a number of excep- 
tions from the sequence XhXhGXGXX% occur. 
For instance, the phosphoryl-binding loop of 
lobster glyceraldehyde-3-phosphate dehydrogen- 
ase, located near the amino terminus of the pro- 
tein, follows the dinucleotide consensus sequence 
4GIDGFGRIGR13 [50,51] with the exception of the 
second hydrophobic residue, which is replaced by 
an aspartic acid residue. Other examples of 
dinucleotide proteins in which the consensus 
sequence has not been found are mercuric re- 
ductase and yeast alcohol dehydrogenase (table 2). 
4. A COMPARISON BETWEEN THE 
(PYRO)PHOSPHATE-BINDING 
SEQUENCES OF MONO- AND 
DINUCLEOTIDE-BINDING PROTEINS 
In all cases studied one observes a P-strand con- 
nected to an a-helix via a short loop in the (pyro)- 
phosphate-binding region. In and bordering the 
loop, one can distinguish a number of critically 
placed glycine residues which facilitate the forma- 
tion of a sharp bend in the loop region. Parti- 
cularly noticeable is a glycine residue near the 
beginning of the a-helix and situated close to a 
Table 2 
Dinucleotide-binding proteins 
Residue Sequence 
number 
Glutathione reductase, FAD-binding domain 
(human) 
Glutathione reductase, NADPH-binding 
domain (human) 
p-Hydroxybenzoate hydroxylase 
Alcohol dehydrogenase (horse liver) 
Lactate dehydrogenase (dogfish, muscle) 
Lactate dehydrogenase (pig, muscle) 
Lactate dehydrogenase (pig, heart) 
D-Amino acid oxidase 
Lipoamide dehydrogenase (pig heart) 
Lipoamide dehydrogenase (E. coli), 
FAD-binding domain 
Lipoamide dehydrogenase (E. coli), 
NAD-binding domain 
Mercuric reductase, FAD-binding domain 
Mercuric reductase, NADP-binding domain 
Glyceraldehyde-3-phosphate d hydrogenase 
(lobster) 
Alcohol dehydrogenase (S. cerevisiae) 
24-34 LVI GGGSGG_LA 
191-201 VI VGAGYI AVE NADP 
6-16 AI I GAGPSGLL FAD 
196-206 A V F G L GG V GL S NAD 
24-34 TVVGVGAVGMA NAD 
23-33 TVVGVGAVGMA NAD 
24-34 TVVGVGQVGMA NAD 
4-14 VVI GAGVI GLS FAD 
8-18 TV1 GSGPGGYV FAD 
9-19 VVLGAGPAG_YS 
178-188 L V MG GGI I GL E 
102-112 AVI GS GGAAMA 
274-284 AVI GS S VVALE 
FAD 
NAD 
FAD 
NADP 
4-14 GLDGFGRI GRL 
196-207 RVL Gl DG_GEGKE 
NAD 
NAD 
co- 
enzyme 
FAD 
Ref. 
1521 
1521 
1531 
[541 
[551 
[561 
t561 
[571 
[581 
1591 
[591 
(601 
1601 
[5Il 
[6Il 
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Table 3 
Structure of phosphate-binding sites in mono- and dinucleotide-binding proteins, as determined by X-ray 
CrystalIography 
Residue 
number 
Ref. 
(A} Mononucleotide-binding proteins 
Adenylate kinase (pig) 
(B) Dinucleotide-binding proteins 
Glutathione reductase (FAD domain) 
&sheet a-helix 
lo-25 I I F VVGaP GS GKGfrQC- [10,21-231, 
22-34 [45,521 
~-Hydroxybenzoate hydroxylase 
(FAD-domain) 4-16 ~~A~ 145,531 
Glyceraldehyde-3-phosphate d hydrogenase 
(lobster) 2-14 &%&j%&- [5OSll 
In adenylate kinase, the phosphate group of AMP is wrapped in the loop structure formed by residue 17-22, connecting 
the&sheet and a-helix as shown. In dinu~leotide-binding proteins, the pyrophosphate group is located near the giycine 
residue indicated by an asterisk, at the beginning of the a-helix. The sequence pattern of the phosphate-binding re ion 
in the given three-dimensional structures is in agreement with the proposed consensus sequences (see tables 1 and 2). 
For none of the other proteins discussed has the three-dimensional structure, including the (pyro)phosphate-binding site, 
been published 
phosphate group. This feature is in agreement with 
the notion of an electrostatically favorable interac- 
tion between an anion and the positive end of an 
a-helix dipole [46], Dinucleotide-binding proteins 
follow the sequence GXGXXG in which the first 
glycine is close to the purine neighboring ribose, 
the second close to the p~ophosphate and the 
third near the beginning of the cu-helix. Following 
the third glycine, one usually sees a hydrophobic 
residue. 
In mononucleotide-binding proteins the se- 
quence GXXXXGK is part of a loop which in the 
case of adenylate kinase is larger (table 3). The 
presence of a lysine next to the second glycine is in- 
triguing. The general occurrence of a positively 
charged residue at this position (see table 1) may 
reflect neutralization of the extra negative charge 
of a free vs an internal pyrophosphate group. 
Although the consensus sequences of 
mononucleotide-binding proteins as reported here 
are rather short, they are representative of 
(pyro)phosphate binding loops, especially if one 
includes the glycine, serine or threonine residue 
found at the position following the common se- 
quence GXXXXGK. This conclusion is based on a 
search of the Protein Segment Dictionary of 
Dayhoff et al. [62]. Apparently, this unique con- 
sensus equence forms a subclass of a more general 
class of strand motifs in which certain 
hydrophobic amino acids stabilize &sheet interac- 
tions and in which criticaIly placed glycine residues 
induce the formation of a flexible Ioop, that ac- 
commodates a negatively charged group. 
In L7/L12 proteins, this group is a sulphate ion 
bound at the beginning of an a-helix preceded by 
a&sheet via a short loop [63]. The sequence in this 
&sheet/cz-helix unit is XhXhXXXG and is well 
conserved for 15 different prokaryotic and 
eukaryotic L7/Ll2 proteins (164,653 and 
unpublished). 
5. COMPLEMENTARY NUCLEOTIDE- 
BINDING SITES 
Besides mutations in position 12 changes at posi- 
tion 59161 of P21 proteins also alter the oncogenic 
and GTP-dependent properties of rus oncogene 
products [11,66]. At present, little is known about 
the possible reason for this effect at position 61. 
Leberman and Egner 1671 compared protein se- 
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quences around position I10 in P21 protein and 
found in this region of P21 certain homologies 
with EF-Tu and some adenine nucleotide binding 
proteins, including adenylate kinase. Interestingly, 
the homologous part of the chain, notably around 
position 110 of this kinase, runs in its three- 
dimensional structure [IO] just behind the ribose 
and base moiety of AMP. Conceivably, 
homologies found in the region of position 110 in 
P21 protein and adenylate kinase reflect the con- 
servation of a complementary nucleotide-binding 
site. 
1131 
u41 
PSI 
I161 
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